Tomer Gold
Directeur Technique/Scientifique/R&D chez Dexcel Pharma Technologies Ltd.
Profil
Tomer Gold is currently the Vice President-Research & Development at Dexcel Pharma Technologies Ltd.
He previously worked as an Independent Director at Cynapsus Therapeutics, Inc. from 2014 to 2016.
Mr. Gold received his undergraduate and graduate degrees from Technion-Israel Institute of Technology.
Postes actifs de Tomer Gold
Sociétés | Poste | Début |
---|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Directeur Technique/Scientifique/R&D | 01/01/2011 |
Anciens postes connus de Tomer Gold
Sociétés | Poste | Fin |
---|---|---|
CYNAPSUS THERAPEUTICS INC | Directeur/Membre du Conseil | 21/10/2016 |
Formation de Tomer Gold
Technion-Israel Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Cynapsus Therapeutics, Inc.
Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |